Mikkel Werling

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Rituximab maintenance after first-line rituximab-bendamustine.

Rituximab maintenance after first-line rituximab-bendamustine.

Journal: Blood advances

Published: March 25, 2026

Rituximab maintenance after first-line rituximab-bendamustine.

Rituximab maintenance after first-line rituximab-bendamustine.

Journal: Blood advances

Published: March 25, 2026

Effects of chronic lymphocytic leukaemia (CLL)-directed therapy on diffuse large B-cell lymphoma (DLBCL) type Richter transformation compared to de novo DLBCL in a nationwide cohort.

Effects of chronic lymphocytic leukaemia (CLL)-directed therapy on diffuse large B-cell lymphoma (DLBCL) type Richter transformation compared to de novo DLBCL in a nationwide cohort.

Journal: British journal of haematology

Published: March 12, 2026

The Danish Lymphoid Cancer Research (DALY-CARE): Genetic Cohort Profile.

The Danish Lymphoid Cancer Research (DALY-CARE): Genetic Cohort Profile.

Journal: Clinical epidemiology

Published: March 06, 2026

Disentangling shifting demographic and treatment effects on years of life lost to cancer in Denmark.

Disentangling shifting demographic and treatment effects on years of life lost to cancer in Denmark.

Journal: npj aging

Published: January 06, 2026

CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomas.

CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomas.

Journal: Blood neoplasia

Published: December 29, 2025

Machine Learning for Prediction of High-Risk Infections in Patients With Cancer.

Machine Learning for Prediction of High-Risk Infections in Patients With Cancer.

Journal: Cancer medicine

Published: December 18, 2025

Post-treatment infection prediction in CLL using domain adaptation of lymphoma electronic health records.

Post-treatment infection prediction in CLL using domain adaptation of lymphoma electronic health records.

Journal: Acta oncologica (Stockholm, Sweden)

Published: September 20, 2025

Machine Learning for Prediction of High-Risk Hospitalizations in Lymphoma Patients: A Danish Population-Based Study.

Machine Learning for Prediction of High-Risk Hospitalizations in Lymphoma Patients: A Danish Population-Based Study.

Journal: European journal of haematology

Published: April 02, 2025

Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer.

Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer.

Journal: HemaSphere

Published: March 27, 2025

The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology.

The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology.

Journal: Clinical epidemiology

Published: July 25, 2024

Showing 1-11 of 11

Last Updated: 09/26/2026